Technical Development of a New Meningococcal Conjugate Vaccine - Wikidata - wikimedia - TriplyDB

Technical Development of a New Meningococcal Conjugate Vaccine

Technical Development of a New Meningococcal Conjugate Vaccine

http://www.wikidata.org/entity/Q26778279

about

Factors contributing to the immunogenicity of meningococcal conjugate vaccines Vaccine Prevention of Meningococcal Disease in Africa: Major Advances, Remaining Challenges.Developmental strategy fora new Group A meningococcal conjugate vaccine (MenAfriVacR).Impact of serogroup A meningococcal conjugate vaccine for Africa.Brazilian meningococcal C conjugate vaccine: physicochemical, immunological, and thermal stability characteristics.Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.Meningococcal Vaccines: Current Status and Emerging Strategies.

P2860

Q28828544-7107D2A8-3A18-402D-A04F-37B483BD3825 Q46535546-0CA2755F-63A0-442E-923F-95F4392B27F0 Q46758477-49B22D5D-CFD4-4E2C-9ACE-B47D9AECB1CD Q46901358-F4102AF4-312A-4AAD-BC78-66763B019F5F Q47774166-5FE226A9-22CD-4D67-BD28-5BFCF2400E31 Q47920054-A3746CC6-B997-4ED1-9B2B-DE97E7C61388 Q52679153-833B1B6A-EBD7-4D85-95D2-A765558E4440

P2860

Technical Development of a New Meningococcal Conjugate Vaccine

http://www.wikidata.org/entity/Q26778279

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Technical Development of a New Meningococcal Conjugate Vaccine

@ast

Technical Development of a New Meningococcal Conjugate Vaccine

@en

Technical Development of a New Meningococcal Conjugate Vaccine

@nl

type

label

Technical Development of a New Meningococcal Conjugate Vaccine

@ast

Technical Development of a New Meningococcal Conjugate Vaccine

@en

Technical Development of a New Meningococcal Conjugate Vaccine

@nl

prefLabel

Technical Development of a New Meningococcal Conjugate Vaccine

@ast

Technical Development of a New Meningococcal Conjugate Vaccine

@en

Technical Development of a New Meningococcal Conjugate Vaccine

@nl

P1433

Q26778279-A3F5B581-E257-4D30-B9CC-ABA554D7A60F

P1476

Q26778279-AD57FDAF-0953-4284-858A-ED6E44153E66

P2093

Q26778279-0E4C204C-9482-45F6-9FDE-958C097C32AD

Q26778279-52A6D0F9-9B26-4708-8E47-4B3600DAB74E

Q26778279-75089396-C4CB-413C-A43F-BD31F0B84F03

Q26778279-A002937D-5317-477A-949D-5D979A0F5404

P275

Q26778279-3CC617A1-14A6-48FE-A08B-1636B55F56AC

P2860

Q26778279-2060AB60-8773-41FB-BD59-F3D998D1257A

Q26778279-3048F8F0-FA63-416E-B4C8-D32E05D12BE2

Q26778279-3416B5B7-373E-45E4-8745-2AE6DCC8CF1F

Q26778279-4496C091-FC86-4291-9853-37FFA7974107

Q26778279-4AE4FB32-9B91-43CC-9B1C-46768798418E

Q26778279-51A69827-D917-46DE-AA49-9A406E5154AA

Q26778279-7D444F5D-7836-46CA-B9F0-2D7A18DBF9E0

Q26778279-7DB87236-55FC-4C27-9138-2A6C99A527D9

Q26778279-987D6C06-AD72-4FBD-87F5-62B8CFD6EB63

Q26778279-A69E86D6-95A8-42C2-8217-896CA247AB04

P304

Q26778279-B671E242-2667-4CA6-A1AB-0327EFE5E8F3

P31

Q26778279-1E54316F-7270-4B1B-A009-51FB6393D7A4

Q26778279-FDDB8F26-B4EC-4878-9832-9DC654611C56

P356

Q26778279-F1AFDA87-8DD9-4802-85FD-CFE44C97DC1A

P407

Q26778279-F862EB11-0896-4939-BDF1-22CEE64A7267

P433

Q26778279-5AEDC1B7-B955-4EA6-9035-5B971098A207

P478

Q26778279-29AD2849-2BFE-4DCE-B568-FEE1E46FBDDF

P5008

Q26778279-A1C75369-0550-4D85-B9A0-AA76063303A5

P577

Q26778279-70EDC677-A25B-4B08-AF20-3CC770733106

P5875

Q26778279-180328C4-8F8F-4412-BD15-D5CED6BDE9D1

P698

Q26778279-DDB5FE82-E93B-40C6-9042-0ACEDE7360A8

P921

Q26778279-0316C695-AB5C-48F1-A2C9-902A4D97064D

Q26778279-56D716A9-C018-4486-8CC1-5ACC4E9126B4

Q26778279-94535A58-68FD-4A70-A564-C648C2E734F3

Q26778279-A285E3C2-BDDE-4027-8AB9-BE0CBFA514F2

P932

Q26778279-539AB331-43DE-4715-9623-511BBFFB620B

P356

P1433

Clinical Infectious Diseases

P1476

Technical Development of a New Meningococcal Conjugate Vaccine

@en

P2093

Carl E Frasch

http://www.w3.org/2001/XMLSchema#string

Che-Hung Lee

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Préaud

http://www.w3.org/2001/XMLSchema#string

Subhash V Kapre

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For Africa

Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine

CEREBROSPINAL MENINGITIS IN AFRICA

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.

Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses.

Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine.

Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).

Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.

Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges.

The epidemiology of meningococcal disease in India.

P304

S404-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIV595

http://www.w3.org/2001/XMLSchema#string

P407

P433

suppl 5

http://www.w3.org/2001/XMLSchema#string

P478

61 Suppl 5

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283810466

http://www.w3.org/2001/XMLSchema#string

P698

26553667

http://www.w3.org/2001/XMLSchema#string

P921

vaccine development

biomedical investigative technique

meningococcal meningitis

P932

4639497

http://www.w3.org/2001/XMLSchema#string